RTIL 13 structure
|
Common Name | RTIL 13 | ||
|---|---|---|---|---|
| CAS Number | 1009376-10-6 | Molecular Weight | 571.67 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C30H55BrN2O3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of RTIL 13RTIL 13 is a potent inhibitor of dynamin GTPase, with an IC50 of 2.3 µM for dynamin I GTPase. RTIL 13 also targets pleckstrin homology lipid binding domain. RTIL 13 can inhibit receptor-mediated and synaptic vesicle endocytosis, with IC50s of 9.3 μM and 7.1 μM, respectively[1][2]. |
| Name | RTIL 13 |
|---|
| Description | RTIL 13 is a potent inhibitor of dynamin GTPase, with an IC50 of 2.3 µM for dynamin I GTPase. RTIL 13 also targets pleckstrin homology lipid binding domain. RTIL 13 can inhibit receptor-mediated and synaptic vesicle endocytosis, with IC50s of 9.3 μM and 7.1 μM, respectively[1][2]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 2.3 µM (dynamin I GTPase)[1] |
| In Vitro | RTIL 13 inhibits receptor-mediated and synaptic vesicle endocytosis, with IC50s of 9.3 μM and 7.1 μM, respectively[2]. |
| References |
| Molecular Formula | C30H55BrN2O3 |
|---|---|
| Molecular Weight | 571.67 |
| InChIKey | NBQBCVMTAUPTCJ-PNXVFTDZSA-M |
| SMILES | CCCCCCCCCCCCCCCCCC[N+](C)(C)CCN1C(=O)C2C3CCC(O3)C2C1=O.[Br-] |
| Hazard Codes | Xi |
|---|